It’s going to take more than record earnings to impress investors this season
Q2 earnings season off to a great start, but investors not always rewarding big beats, more focused on forward looking forecasts.
Read MoreQ2 earnings season off to a great start, but investors not always rewarding big beats, more focused on forward looking forecasts.
Read MoreIf you feel like you are experiencing deja vu at the start of this earnings season, you aren’t mistaken. In similar fashion to the Q1 season, we head into second quarter reports after hitting a fresh S&P 500 intraday high of 4,365.89 on Friday f
Read MoreS&P 500 firms have easily beaten analyst earnings expectations four quarters in a row—the drive for five is on! We feature two earnings outliers this week as the second quarter reporting season begins.
Read MoreNearly 16 months after the COVID-19 pandemic halted in-person movie-going, studios are hoping pent-up demand will feed box office numbers this summer.
Read MoreConferences, forums, summits, and trade shows are among the most important events traders must mark on their calendars. Stock-specific news is often released at these gatherings of executives, analysts, and industry experts.
Read MoreTraders are gearing up for another earnings season. S&P 500 companies have handily beaten analyst expectations in each of the last four reporting periods, so expectations are likely growing loftier.
Read MorePrescription Drug User Fee Act (PDUFA) dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn
Read MoreThis week, we feature insights on what companies are doing with their cash flow in light of the much better than expected operating conditions. We also investigate one small U.S. firm as an Earnings Outlier that traders should keep on their radar.
Read More